This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nanohybrid Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Jae-Min Oh in Injectable Drug Carriers
Introduction
Jae-Min Oh is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on injectable drug carriers. His research focuses on enhancing the efficiency of drug delivery while ensuring safety and efficacy.
Latest Patents
Jae-Min Oh holds 1 patent for his invention titled "Injectable drug carrier comprising layered double hydroxide." This patent describes an injectable drug carrier that includes a non-toxic Layered Double Hydroxide (LDH) combined with pharmaceutically acceptable excipients. The method of preparing this injectable drug carrier involves synthesizing LDH with various compositions and controlling its size and shape to ensure it has no adverse effects in vivo. The resulting solution, when injected, allows for the delivery of nano-sized LDH that does not negatively impact blood vessels, even at concentrations of 400 mg/kg. This innovation aims to improve the delivery efficiency of specific drugs.
Career Highlights
Jae-Min Oh is associated with Nanohybrid Co., Ltd., where he continues to develop and refine his innovative drug delivery systems. His work is pivotal in advancing the field of pharmaceuticals, particularly in creating safer and more effective methods for drug administration.
Collaborations
Jae-Min Oh collaborates with talented individuals such as Jin-Ho Choy and Taeun Park, who contribute to the research and development efforts at Nanohybrid Co., Ltd. Their combined expertise enhances the potential for groundbreaking advancements in drug delivery technologies.
Conclusion
Jae-Min Oh's contributions to the field of injectable drug carriers represent a significant step forward in pharmaceutical innovation. His work not only addresses critical challenges in drug delivery but also paves the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile